Author: Mark Newman

Share

EDCs in Plastics, Pesticides, and Other Sources Pose Health Threats Globally

Everyday exposures to EDCs in the environment may be linked to increasing rates of infertility, diabetes, immune deficiencies, and other serious conditions  Highly Hazardous Pesticides pose ongoing threats, especially in the Global South  A report from the world’s leading scientific and medical experts on hormone-related health conditions raises new concerns about the profound threats to...
Share

New Position Statement Focuses on Patient Experience in Diabetes Care

Healthcare providers who treat diabetes need to think beyond the clinical numbers, such as solely focusing on a person’s glucose goals. Taking the patient experience into account can improve the quality of care and facilitate attainment of treatment goals, according to a new position statement published in the Endocrine Society’s Journal of Clinical Endocrinology &...
Share

Pharma Fridays – February 16, 2024

An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Medicare Coverage Significantly Expanded for the Eversense E3 CGM System On February 12, Ascensia Diabetes Care, announced that Medicare has significantly expanded access to the Eversense E3 CGM System with the implementation of Local Coverage Determinations providing access to implantable CGM...
Share

Pharma Friday – February 9

An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Spruce Biosciences Completes Enrollment in CAHmelia-204 Study for Adult Classic Congenital Adrenal Hyperplasia Last month, Spruce Biosciences, announced completion of enrollment in its CAHmelia-204 clinical trial of tildacerfont for the treatment of adult classic congenital adrenal hyperplasia (CAH). Spruce Biosciences is...
Share

Introducing EndoForum, the Endocrine Society’s Rebranded Online Community

After initially launching in 2022 and growing into a thriving community in 2023, the Endocrine Society’s online community in DocMatter is ready to step out into the spotlight with a brand-new name: EndoForum!  Why change the name? EndoForum is more than just the platform it’s on; it is a vibrant and active community of more than 16,000 Endocrine Society...
Share

Endocrine Society Journals Remain Premier Venue for Publishing Endocrine Research

Hammes-ENDO 2022RESIZED Year after year, I am continually impressed with the quality and quantity of research that is published in the Society’s suite of scientific journals. As the former co-editor-in-chief, with Andrea Gore, of the Society’s basic science flagship journal Endocrinology, and editor-in-chief of the Society’s other previous basic science journal, Molecular Endocrinology, I was privileged to...
Share

Advocacy Update: February 2024

Federal Funding for SDP, NIH in Jeopardy As the February issue of Endocrine News went to press, the government had only days to fund the Special Diabetes Program (SDP) and the National Institutes of Health (NIH) before funding expired.  It was expected that Congress would pass another short-term funding bill that would fund these programs...
Share

Focusing on Thyroid Cancer

Mark Headshot As we start the year, we are devoting the lion’s share of the editorial pages this month to thyroid cancer. From its diagnosis and treatment to detailed studies about hypoparathyroidism, risk stratification for thyroid nodules, and more. With thyroid cancer being the most common endocrine cancer in the world, we thought it would be appropriate...